Holen Sie sich die Stockscreener-App
4.33
4.59%
0.19
Vorhandelsmarkt:
4.41
0.08
+1.85%
Schlusskurs vom Vortag:
$4.14
Offen:
$4.215
24-Stunden-Volumen:
3.86M
Relative Volume:
0.88
Marktkapitalisierung:
$1.54B
Einnahmen:
$9.68M
Nettoeinkommen (Verlust:
$-250.64M
KGV:
-3.0933
EPS:
-1.3998
Netto-Cashflow:
$-89.83M
1W Leistung:
+7.71%
1M Leistung:
+9.90%
6M Leistung:
+8.52%
1J Leistung:
+184.87%
1-Tages-Spanne:
$4.17
$4.405
1-Wochen-Bereich:
$3.92
$4.405
52-Wochen-Spanne:
$1.225
$5.465
Precigen Inc Stock (PGEN) Company Profile
Firmenname
Precigen Inc
Sektor
Branche
Telefon
301-556-9900
Adresse
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
4.33 | 1.54B | 9.68M | -250.64M | -89.83M | -1.3998 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-03-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Eingeleitet | JP Morgan | Neutral |
| 2022-11-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-02-25 | Eingeleitet | Stifel | Buy |
| 2021-02-22 | Eingeleitet | Wells Fargo | Overweight |
| 2021-02-18 | Eingeleitet | B. Riley Securities | Buy |
| 2020-05-08 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Precigen Inc Aktie (PGEN) Neueste Nachrichten
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now? - Insider Monkey
Precigen, Inc. (PGEN) reports Q4 loss, lags revenue estimates - MSN
Precigen (NASDAQ: PGEN) 2026 proxy details director, pay and equity plan votes - Stock Titan
Precigen (PGEN) price target increased by 11.76% to 9.69 - MSN
Precigen gains after 2025 results on Papzimeos' outlook - MSN
These analysts boost their forecasts on Precigen following Q4 results - MSN
Top Growth Companies With Insider Stakes In April 2026 - simplywall.st
Precigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Precigen files to sell 143.81M shares of common stock for holders - MSN
Precigen (PGEN) Stock: Technical Risk Signals | Q4 2025: EPS Tops ViewsSocial Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai
PGEN (Precigen) beats Q4 2025 EPS expectations, posts 146.7 percent revenue growth as shares rise 3.27 percent.Recovery Stocks - Cổng thông tin điện tử tỉnh Lào Cai
PGEN (Precigen Inc.) reports narrower Q4 2025 loss than estimates, shares rise slightly on positive investor sentiment.Consensus Forecast - UBND thành phố Hải Phòng
Precigen (PGEN) COO Rutul Shah receives new RSU and stock option grants - Stock Titan
Precigen (PGEN) awards RSUs and stock options to Chief Legal Officer - Stock Titan
Precigen (PGEN) CEO receives large RSU and stock option grants - Stock Titan
Precigen (PGEN) awards CCO 115,000 RSUs and 385,000 options - Stock Titan
Precigen (PGEN) CFO receives 120,000 RSUs and options on 399,000 shares - Stock Titan
Precigen expects Q1 revenue to exceed $18M as PAPZIMEOS launch accelerates with broad US payer coverage - MSN
Wall Street bullish on Precigen (PGEN) as the company transitions to commercial stage - MSN
Precigen (NASDAQ:PGEN) Trading Up 7.5%Still a Buy? - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Q4 2025 earnings call transcript - MSN
Is Precigen’s (PGEN) New PAPZIMEOS J-Code Reframing Its Respiratory Growth Narrative? - simplywall.st
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million - ACCESS Newswire
Precigen (NASDAQ:PGEN) Trading Down 5.6%Here's Why - MarketBeat
Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy? - Insider Monkey
Aug Closing: Whats the fair value of Precigen Inc stockMarket Performance Recap & Expert Curated Trade Ideas - baoquankhu1.vn
Take Profit: Is Precigen Inc a turnaround storyWeekly Gains Summary & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Precigen, Inc. (PGEN) poised for growth on respiratory papillomatosis treatment prospects - MSN
Wall Street Bullish on Precigen (PGEN) As the Company Transitions to Commercial Stage - Insider Monkey
Take Profit: What are Precigen Incs recent SEC filings showingGap Down & Weekly High Conviction Trade Ideas - baoquankhu1.vn
CapEx per share of Precigen Inc – SWB:I5X - TradingView — Track All Markets
Finanzdaten der Precigen Inc-Aktie (PGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):